Support from The Michael J. Fox Foundation for Parkinson’s Research to advance critical research into Parkinson’s disease biology • Nautilus’ ...
The partnership is supported by the Michael J. Fox Foundation, which seeks to better understand aSyn protein's role in Parkinson's disease.
Researchers show that immune cells transport toxic alpha-synuclein from the gut to the brain, supporting the theory that Parkinson's may start in the gut. The findings identify a new immune-driven ...
The MarketWatch News Department was not involved in the creation of this content. SynuSight Biotech has licensed (18) F-FD4 to XingImaging and to ABLi Therapeutics to evaluate alpha-synuclein ...
Amsterdam, July 22, 2024 – To date Parkinson's disease (PD) is diagnosed clinically and rather late in the course of the disease. There is an urgent need to find an objective, quantifiable biomarker ...
Data from the Syn-Sleep Study shows the Syn-One Test detected phosphorylated alpha-synuclein in skin biopsies of 75% of patients with iRBD at baseline This NIH-sponsored, multicenter, prospective ...
Data provide validation of the Vaxxinity (VAXX) platform’s ability to selectively target aggregated, toxic forms of neurodegenerative proteins UB-312 is designed to target aggregated forms of aSyn, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results